citalopram
Commercial- Indications
- major depressive disorder (MDD)
Company intelligence / Profile preview
Forest Laboratories
New York City, New York, United Statesen.wikipedia.org ↗
- Ownership
- Private
- Employees
- ~6200
- Development stage
- Commercial
01
Overview
Forest Laboratories was known for licensing European pharmaceuticals for sale in the United States. The company had several commercial products including Celexa and Lexapro for depression.
- Therapeutic areas
- GastroenterologyNeurologyPsychiatryCardiovascular
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
GlaxoSmithKline (for Lamictal ODT)
Beyond the preview
Go deeper on Forest Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Forest Laboratories.